Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35179589.
- Also identified by DOI 10.1001/jamanetworkopen.2022.0040 and PMC identifier 8857682.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study examines the prevalence and necessity of antimicrobial drug use among patients who are hospitalized with COVID-19 infection in Japan.
Medical subject headings
- Anti-Bacterial Agents
- COVID-19
- Hospitalization
- Practice Patterns, Physicians'
- SARS-CoV-2